MYC and glioblastoma: Furthermore, our research revealed that reducing c-myc expression led to a suppression of malignant progression in GBM cells, likely due to the direct negative impact of c-myc inactivation on the oncogenic pathways driving GBM (Fig. 6P-S and S6O-T).